Lemus David 4
4 · Sorrento Therapeutics, Inc. · Filed Nov 16, 2017
Insider Transaction Report
Form 4
Lemus David
Director
Transactions
- Award
Stock Options
2017-11-14+35,000→ 35,000 totalExercise: $2.30Exp: 2027-11-14→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]1/12 of the original number of shares subject to this option is immediately vested and exercisable. 1/12 of the original number of shares subject to this option shall vest and become exercisable on November 26, 2017 and 1/12 of the original number of shares subject to the option shall vest following each one month of service thereafter, subject to the Reporting Person's continued service on the Issuer's board of directors on each such date.